We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPMA:NYSESound Point Meridian Capital, Inc. 8.00% Series A Preferred Shares Due 2029 Analysis

Data as of 2026-05-02 - not real-time

$25.10

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock is trading in a tight range with the 20‑day, 50‑day and 200‑day moving averages virtually overlapping, indicating a neutral technical backdrop. RSI sits around the midpoint and the MACD histogram is slightly negative, suggesting modest bearish pressure as price hovers near the identified resistance. The beta is exceptionally low and 30‑day volatility modest, so market‑wide swings are unlikely to move the share dramatically, but the volume profile is thin, raising execution concerns. Fundamentally, the company shows zero revenue growth, a thin profit margin, and a sizable debt load that dwarfs its cash position, while operating cash flow is deeply negative. The headline dividend yield appears attractive, yet the payout ratio is effectively undefined and the cash‑flow profile signals that the dividend may not be sustainable.
Given the combination of a marginally bearish technical signal, fragile cash fundamentals, and a high‑yield dividend that could be at risk, the outlook leans toward caution. Investors should monitor any dividend policy changes and debt‑service developments closely; absent a clear turnaround, the stock is better suited for defensive positioning rather than aggressive accumulation.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD histogram
  • Price testing resistance with limited upside
  • Dividend sustainability doubts

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Neutral technical trend
  • High dividend yield may attract income seekers
  • Ongoing negative operating cash flow and high debt

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Persistent lack of revenue growth
  • Elevated leverage relative to equity
  • Potential dividend cuts if cash constraints worsen

Key Metrics & Analysis

Financial Health

Profit Margin7.71%
Debt/Equity62.96
P/B Ratio1.8
Op. Cash Flow$-122608096
Industry P/E17.5

Technical Analysis

TrendNeutral
RSI52.2
Support$24.99
Resistance$25.40
MA 20$25.11
MA 50$25.06
MA 200$25.12
MACDBearish
VolumeStable
Fear & Greed Index91.09

Valuation

GradeOvervalued
TypeValue
Dividend Yield7.97%

Risk Assessment

Beta0.06
Volatility3.36%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.